Mushrooms Nutraceuticals and Functional Foods Editors: Deepu Pandita Senior Lecturer Government Department of School Education, Jammu Union Territory of Jammu and Kashmir, India Anu Pandita Dietician, Vatsalya Clinic New Delhi, India p, A SCIENCE PUBLISHERS BOOK A SCIENCE PUBLISHERS BOOK First edition published 2023 by CRC Press 6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL 33487-2742 and by CRC Press 4 Park Square, Milton Park, Abingdon, Oxon, OX14 4RN © 2023 Deepu Pandita and Anu Pandita CRC Press is an imprint of Taylor & Francis Group, LLC Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, access www.copyright.com or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. For works that are not available on CCC please contact [email protected] Trademark notice: Product or corporate names may be trademarks or registered trademarks and are used only for identification and explanation without intent to infringe. Library of Congress Cataloging-in-Publication Data (applied for) ISBN: 978-1-032-34453-9 (hbk) ISBN: 978-1-032-34456-0 (pbk) ISBN: 978-1-003-32223-8 (ebk) DOI: 10.1201/9781003322238 Typeset in Times New Roman by Radiant Productions Preface Worldwide 1.5 million fungi are assessed, out of which around 14,000 species produce the fruiting bodies known as mushrooms and around 2000 species are edible and 270 are reported to be medicinal. The fungal kingdom is phylogenetically closer to man than plant kingdom. So, it is believed that fungi may give better health benefits to human systems. These mushrooms with nutraceutical and pharmacological properties may help in designing of health- enhancing myco-foods and myco-pharmaceuticals. The nutraceutical word is a juxtaposition of “nutrition” and “pharmaceuticals” and means any substance which may be considered a food or part of food and provides health-improving effects, prevents and cures some human disorders. Mushrooms are known as poor people’s protein ‘elixir of life’, ‘the gift from God Osiris’ and ‘the food of the Gods’. Mushrooms are labelled as the “little miniature chemical factories” that produce a gigantic collection of novel components and active secondary metabolites and nutraceuticals. Due to their nutritional profile, edible and medicinal mushrooms are considered healthy dietary food, functional food or nutraceuticals such as phenolics, polyketides, flavonoids, α-tocopherol, terpenoids, immunostimulatory glucans, lectins and steroids, ergothioneine, polysaccharides, Polyunsaturated fatty acids (PUFA) especially the n-3-fatty acid family, lysine and leucin amino acids and other bioactive molecules which possess more than 130 medicinal properties and act as immune enhancers, anti-carcinogenic, antitumor, hepatoprotective, anti-HIV anti-diabetic, anti-obesity, anti-hypercholesterolemic, antimicrobial, anti-inflammatory, anti-nephritis, immunomodulatory, cardio protective, anti-aging, anti-arthritis, reduce or prevent age-related neurodegenerative processes, such as Alzheimer’s and Parkinson’s diseases, etc. This book contains 23 chapters with the introductory chapter discussing the antioxidant and secondary metabolite profiling of mushrooms as sources of Nutraceuticals and Functional foods. The other chapters deliberate the nutraceutical and functional foods aspects of Agaricus bisporus (Button Mushroom), Agaricus subrufescens (God’s mushroom), Armillaria mellea (Honey Fungus), Auricularia auricula-judae (Jelly Ear), Auricularia polytricha (Cloud Ear Fungus), Calvatia gigantean (Giant Puffball), Cantarellus cibarius (Girolle), Craterellus cornucopioides (Black Trumpet), Flammulina velutipes (Velvet Shank), Ganoderma lucidum (Reishi mushroom), Grifola frondosa (Maitake), Hericium erinaceus (Lion’s Mane), Lentinula edodes (Shiitake), Lignosus rhinocerotis (Tiger Milk Mushroom), Morchella esculenta (Gucchi), Ophiocordyceps sinensis (Cordyceps), Pleurotus ostreatus (Oyster Mushroom), Polyporus confluens (Sheep Polypore), Trametes versicolor (Turkey Tail), Tremella fuciformis (Snow Ear), Volvariella volvacea (Paddy Straw Mushroom), and Wolfiporia extensa (Peck) Ginns. (China Root). Contents Preface iii 1. Antioxidants and Secondary Metabolites of Mushrooms as a Source 1 of Nutraceuticals and Functional Food Ankur Singh and Aryadeep Roychoudhury 2. Button Mushroom (Agaricus bisporus) 15 Aliza Batool, Umar Farooq, Afshan Shafi, Naqi Abbas, Zahid Rafiq and Zulqurnain Khan 3. God’s Mushroom (Agaricus subrufescens) 34 Parthasarathy Seethapathy, Praveen Thangaraj, Anu Pandita, Subbiah Sankaralingam and Deepu Pandita 4. Honey Fungus (Armillaria mellea) 48 Bushra Hafeez Kiani 5. Jelly Ear (Auricularia auricula-judae) 66 Mona Kejariwal 6. Cloud Ear Fungus (Auricularia polytricha) 77 Siriporn Chuchawankul, Sharika Rajasekharan, Nichaporn Wongsirojkul and Sunita Nilkhet 7. Giant Puffball (Calvatia gigantea) 96 Rohit Shukla, Mohee Shukla, Saket Jha, Ravikant Singh, Ashutosh Pathak and Anupam Dikshit 8. Girolle (Cantharellus cibarius) 113 Manjula Rai, Shuvadip Mondal, Rupa Sanyal, Abhijit Dey and Surjit Sen 9. Black Trumpet (Craterellus cornucopioides) 131 Karla Hazel Ozuna-Valencia, Ana Laura Moreno-Robles, Francisco Rodríguez-Félix, Maria Jesús Moreno-Vásquez, Carlos Gregorio Barreras-Urbina, Tomás Jesús Madera-Santana, Saúl Ruíz-Cruz, Ariadna Thalia Bernal-Mercado, Lorena Armenta-Villegas and José Agustín Tapia-Hernández Contents v 10. Velvet Shank (Flammulina velutipes) 153 Vijay Kumar Veena, Adhikesavan Harikrishnan and Purushothaman Maheswari 11. Reishi Mushroom (Ganoderma lucidum) 170 Lepakshi Md. Bhakshu, KV Ratnam, Pulala Raghuveer Yadav, C Meera Saheb, Anu Pandita and Deepu Pandita 12. Grifola frondosa: Nutraceutical and Medicinal Potential 191 Sudha Nandni, Devanshu Dev and Dayaram 13. Lion’s Mane (Hericium erinaceus) 201 Emeric Kochoni and Vincent Ezin 14. Shiitake (Lentinula edodes) 214 Ariadna Thalía Bernal-Mercado, Francisco Rodríguez-Félix, Carlos Gregorio Barreras-Urbina, Tomás Jesús Madera-Santana, Karla Hazel Ozuna-Valencia, Maria Jesús Moreno-Vásquez, Lorena Armenta-Villegas, Carmen Lizette Del-Toro-Sánchez, Miguel Ángel Urías-Torres and José Agustín Tapia-Hernández 15. Tiger’s Milk Mushroom (Lignosus rhinocerus) 239 Phaniendra Alugoju and Tewin Tencomnao 16. Gucchi (Morchella esculenta) 254 Anu Pandita, Deepu Pandita, Jyothi Chaitanya Pagadala, Sugumari Vallinayagam, Bhoomika Inamdar, Manohar MV, Amogha G Paladhi, Siji Jacob and Devananda Devegowda 17. Cordyceps (Ophiocordyceps sinensis) 274 Parthasarathy Seethapathy, Anu Pandita, Deepu Pandita, Subbiah Sankaralingam, Harinathan Balasundaram and Kousalya Loganathan 18. Oyster Mushroom (Pleurotus ostreatus) 302 Parthasarathy Seethapathy, Praveen Thangaraj, Anu Pandita, Subbiah Sankaralingam and Deepu Pandita 19. Sheep Polypore (Polyporus confluens) 322 Ikbal Hasan, Tuyelee Das, Mimosa Ghorai, Abdel Rahman Al-Tawaha, Ercan Bursal, Mallappa Kumara Swamy, Potshangbam Nongdam, Mahipal S Shekhawat, Devendra Kumar Pandey and Abhijit Dey 20. Turkey Tail (Trametes versicolor) 330 Carlos Gregorio Barreras-Urbina, Francisco Rodríguez-Félix, Tomás Jesús Madera-Santana, Eneida Azaret Montaño-Grijalva, Cielo Estefanía Figueroa-Enríquez, Frida Lourdes García Larez, Danya Elizabeth Estrella-Osuna and José Agustín Tapia-Hernández 21. Snow Ear (Tremella fuciformis) 341 Kaksha Sankhe and Tabassum Khan vi Mushrooms: Nutraceuticals and Functional Foods 22. Paddy Straw Mushroom (Volvariella volvacea) 349 Dhiraj L Wasule, Anjali M Gaharwar, Prashant R Shingote and Darasing R Rathod 23. China Root (Wolfiporia extensa (Peck) Ginns) 366 Jeetendra Singh, SK Soni and Rajiv Ranjan Index 377 About the Editors 379 C 1 HAPTER Antioxidants and Secondary Metabolites of Mushrooms as a Source of Nutraceuticals and Functional Food Ankur Singh and Aryadeep Roychoudhury* 1. Introduction Since origin, man has mostly lived in a hunter-gatherer society, depending on the biodiversity of their surroundings for their sustenance. Mushrooms have probably been eaten for as long as people have walked on the surface of the Earth. The history of mushrooms dates back to 300 BC when Theophrastus first mentioned it as ‘truffles’. Romans regarded mushrooms as ‘food of the Gods’ whereas Greek warriors used to consume them during battles to acquire strength. Basidiomycete fungi, during sexual reproduction, produce fruiting bodies that are commonly known as ‘mushrooms’. Spores released from the fruiting bodies germinate to form mycelia which in the presence of suitable substrate (dead branches, fallen leaves, wood, etc.) further develop into primoridia. Finally, primoridia gives rise to the fruiting bodies, i.e., the mushrooms. According to Royse et al. (2017), the production of mushrooms was 30 million tons at a cost of about $63 billion in 2013 which shows a significant rise in the production as compared to that of 1978 when only one million ton of mushrooms was produced worldwide. Of all the cultivated mushrooms, around 54% (~ $34 billion) was edible. Most of the cultivated edible mushrooms consist of five genera: Flammulina (11%), Agaricus (15%), Auricularia (17%), Pleurotus (19%) and Lentinula (22%) (Raut, 2019). For centuries, mushrooms have been widely used as traditional medicines and foods. However, in spite of wide use, the pharmacological and nutritional property of mushrooms has been recently recognised worldwide. In recent times, various scientific reports have described the pharmacological properties (antifungal, Post-Graduate Department of Biotechnology, St. Xavier’s College (Autonomous), 30 Mother Teresa Sarani, Kolkata – 700016, West Bengal, India. * Corresponding author: [email protected] 2 Mushrooms: Nutraceuticals and Functional Foods antibacterial, antiviral, antitumour and immune-stimulant property) of mushrooms and components extracted from them (Ma et al., 2018). Both secondary metabolites and cellular components of a wide variety of mushrooms have scientifically proved to boost the immune system of the host. Secondary metabolites are of great interest to the medical industry due to their unusual structure and active formation. Along with medicinal interest, other fields, such as agricultural and cosmetic industries, also uses metabolites extracted from mushrooms as their raw material. In spite of such a wide role, the identification and characterisation of compounds showing pharmacological response mostly rotates around higher molecular weight compounds, i.e., protein, polysaccharides and peptides, with only a few reports showing the efficacy of low molecular-weight compounds. Thus, this chapter mostly emphasises the importance of bioactive secondary metabolites derived from edible mushrooms in the nutraceutical industries. 2. Nutritional Value of Mushrooms Mushrooms are widely popular due to their high protein content and unsaturated fatty acids. Additionally, mushrooms are also known to be a good source of soluble fibre, particularly β-glucan (Cheung, 2013). Fruiting bodies of mushrooms are mostly composed of carbohydrates (50–60%) and sugars (11%) on dry weight basis (Temesgen, 2018), whereas freshly harvested mushrooms have moisture content of about 70–95% depending mostly on the time of harvest and environmental conditions. Khan and Tania (2012) reported that the carbohydrate content of Pleurotus ostreatus was 56%. Mannitol is a major sugar found in mushrooms, constituting around 80% of total free sugar (Wannet et al., 2000). Another important component that is widely found in fruiting bodies of mushrooms is proteins. As compared to that of other vegetables and wild plants, the protein level in mushrooms is appreciably high. According to a data published by the USDA (2019), the nutrients present in mushrooms are fat (0.34 g/100 g dry weight), fibre (1.0 g/100 g dry weight), protein (3.09 g/100 g dry weight) and carbohydrate (3.23 g/100 g dry weight) which provides 22 kcal of energy upon consuming 100 g raw mushrooms. According to the report published by U.S. Department of Agriculture (2018), the glycaemic index of mushrooms is quite low which does not significantly affect the glucose level and insulin response of consumers. Along with this, mushrooms are also reported to be a good source of micronutrients and mineral elements that are important for maintaining proper health of humans. The major elements found in mushrooms are potassium (K), calcium (Ca), magnesium (Mg), phosphorus (P), iron (Fe), copper (Cu), zinc (Zn) and sodium (Na) (Malinowska et al., 2004). According to Thongbai et al. (2015), mushrooms are also a good source of vitamins, such as vitamin B complex, including vitamin B that plays 5 a major role in the release of energy from fat, carbohydrate and proteins. However, the minerals and nutritional content of the mushrooms mostly depend on the species, age, size of fruiting bodies and the mineral content of the surrounding or substrate supplied at the time of cultivation (Rudawska and Leski, 2005). 3. Economic Importance of Micro Fungal Nutraceuticals In the last decade, the severity of health-related problems has significantly increased due to which the demand for nutraceuticals and dietary supplements has also Mushrooms as Antioxidant and Secondary Metabolite Source 3 parallelly enhanced due to their potential role in improving the life expectancy and preventing health-related disorders in human beings. The nutraceuticals industry first came into existence in 1990s (Ali and Nizar, 2018). From the very beginning, the nutraceuticals market became more competitive due to large investments by higher food and pharmaceutical companies. According to a report published by PMMI Business Intelligence, the global nutraceutical market is expected to grow up to $373 billion by 2025 as against around $241 billion in 2019, i.e., nutraceutical market is expected to grow at a rate of 7.5% compound growth annually (PMMI Business Intelligence, 2019; Chrzan, 2019). Of late, various reports have shown the medicinal importance of consuming mushrooms that acts as a driving force for its increased market demand, thus paving the path for its inclusion in the nutraceutical market. According to a study conducted by Datam Intelligence, the global demand for edible mushrooms is expected to grow at 7.9% compound annual growth rate. Edible mushrooms had a global market value of $42.42 billion in the year 2018, $45.3 billion in 2020, and are forecasted to increase up to $62.19 billion in 2023 and $72.5 billion by 2027 (Research and Markets Global Edible Mushrooms Market). According to a report by Technavio (2018–2022), the market value of major medicinal mushrooms, such as Chaga and Reishi mushrooms, will enhance by $13.88 billion by 2018–2022 in European, American, Middle Eastern and African markets. They further assume that the inclination of people toward vegan diet will boost the market of mushrooms, further increasing the market by 9% compounded annual growth rate during 2018–2022. Various mushroom-based pharmaceuticals, i.e., krestin, lentinan, coriolan, schizophyllan, etc. are already available in the world market (Badalyan, 2014). The market value of soluble fibre glucan, which is highly present in mushrooms, is expected to grow significantly in food, cosmetic and medicinal industries (Venkatachalam et al., 2020). Dietary habits, positive outlook towards nutrient-rich food and change in lifestyle are the major causes of the rise of nutraceutical industry and in coming times, consumer preference for more affordable products will also be a major factor contributing towards the growth of the mushroom industry. 4. Nutraceutical Metabolites of Mushrooms It is obvious that people have been always in search of new substances which can improvise biological significance to make them healthier and fitter. Today science depends on herbs and plants as enhancers of the food sources. These products are regarded as variously functional foods, vitamins, dietary supplements, nutraceuticals, etc. (Chen and Miles, 1996; Brower, 1998; Zeisel, 1999). In this regard, mushrooms are now receiving much appreciation for their health benefits, medicinal and nutritional attributes (Roychoudhury, 2021). Human beings consume mushrooms as dietary ingredients, supplementing and complementing deficiency in food items from animal and plant origin. Unique chemical composition of mushrooms makes them preferable for certain groups of physiological disorders or ailments. Such attributes help mushrooms to be treated as a healthy food. The term ‘nutraceutical’, derived from a combination of two words: ‘nutrition’ and ‘pharmaceutical’, refers to any substance with immense health benefits along with the treatment and prevention of diseases (Biesalski, 2001). Nutraceuticals can be herbal products, isolated nutrients, dietary supplements or engineered and processed food products,